Emil D Kakkis
CIK 1248093 · President & CEO · last filed 2026-04-20
Emil D Kakkis is a President & CEO who has filed 89 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for RARE, was dated Apr 20, 2026. Across all open-market trades the lifetime net is −$54.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $49.5M across reported positions. 71 SEC filings were submitted jointly with Ultragenyx Pharmaceutical Inc. 8 Form 144 notices of planned sales are also on file; the latest, for RARE on Feb 28, 2025, lists the filer as an officer.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
RARE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
60 LEVERONI COURT
NOVATO, CA 94949
Holdings By Company
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| RARE | Direct | 735,739 | 27.3% | 2026-04-20 |
| By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 200909 | 1,758,985 | 65.3% | 2026-04-20 | |
| By GRAT | 200,000 | 7.4% | 2026-04-20 | |
| Total | 2,694,724 | |||
| No longer reported | ||||
| By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009 | 2,158,985 | — | last 2026-03-03 | |
| See FN | 2,223,985 | — | last 2024-09-05 | |
| By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 200 | 2,263,985 | — | last 2024-02-08 | |
| BMRN | Direct | 47,518 | 91.1% | 2009-03-04 |
| Shares held by spouse | 4,654 | 8.9% | 2009-03-04 | |
| Total | 52,172 | |||
| No longer reported | ||||
| Shares held by spouse. | 4,654 | — | last 2008-11-05 | |
| Shared held by spouse | 4,654 | — | last 2008-10-03 | |
Recent Filings
89 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-20 | RARE | Grant (A) | +76,745 | $0 | EDGAR |
| 2026-03-03 | RARE | Mixed | +16,773 | -$1.24M | EDGAR |
| 2025-03-04 | RARE | Mixed10b5-1 | +52,126 | -$4.15M | EDGAR |
| 2025-02-28 | RARE | Notice (144) Officer · Planned Feb 28, 2025 · 10b5-1 plan Sold: Form 4 filed Mar 4, 2025 |
−25,000 | -$1.06M | EDGAR |
| 2024-12-31 | RARE | Sell (S)10b5-1 | −11,727 | -$495.2K | EDGAR |
| 2024-12-30 | RARE | Notice (144) Officer · Planned Dec 30, 2024 · 10b5-1 plan Sold: Form 4 filed Dec 31, 2024 |
−11,727 | -$495.3K | EDGAR |
| 2024-12-11 | RARE | Mixed10b5-1 | −28,273 | -$413.6K | EDGAR |
| 2024-12-10 | RARE | Notice (144) Officer · Planned Dec 10, 2024 · 10b5-1 plan Sold: Form 4 filed Dec 11, 2024 |
−8,273 | -$413.6K | EDGAR |
| 2024-09-05 | RARE | Sell (S)10b5-1 | −20,000 | -$1.12M | EDGAR |
| 2024-09-03 | RARE | Notice (144) Officer · Planned Sep 3, 2024 · 10b5-1 plan Sold: Form 4 filed Sep 5, 2024 |
−20,000 | -$1.12M | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).